First Trust Nasdaq Pharmaceuticals ETF FTXH
43.13 USD -1.78 (-3.96%)
At closeNov 5, 2026, 4:00 PM EST
43.17 +0.04 +0.09%
After hours · Nov 5, 4:00 PM ET
43.11 Day range 45.10
29.89 52-week range 45.10
- YTD
- +30.94%
- 1 year
- +42.87%
- Market cap
- 1.20B
- EPS (ttm)
- 1.69
- P/E ratio
- 25.56
- YTD return
- +30.94%
- 1-year return
- +42.87%
- Volume
- 68.10K
- Avg volume
- 167.05K
- Open
- 45.09
- Previous close
- 44.91
- Day's range
- 43.11 – 45.10
- 52-week range
- 29.89 – 45.10
1Y +12.90 (+42.67%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 41.75
- 200-day average
- 37.30
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
News
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now? 
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)? 
Why Is Eli Lilly Stock Falling Tuesday? 
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now? 
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)? 
Trump to announce discount drug pricing expansion, White House official says 
Could pressure to make money faster kill the next lifesaving pill? 
What's Going On With Bristol-Myers Squibb Stock Today? 
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' 
Pharma ETF (FTXH) Hits New 52-Week High
Your note
Sign in to keep a note on FTXH — it syncs with the Stock Master app.